Your browser doesn't support javascript.
loading
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
Iversen, Ole-Erik; Miranda, Maria Jose; Ulied, Angels; Soerdal, Terje; Lazarus, Erica; Chokephaibulkit, Kulkanya; Block, Stan L; Skrivanek, Ales; Nur Azurah, Abdul Ghani; Fong, Siew Moy; Dvorak, Vladimir; Kim, Kyung-Hyo; Cestero, Ramon M; Berkovitch, Matitiahu; Ceyhan, Mehmet; Ellison, Misoo C; Ritter, Michael A; Yuan, Shuai S; DiNubile, Mark J; Saah, Alfred J; Luxembourg, Alain.
  • Iversen OE; Department of Obstetrics and Gynecology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
  • Miranda MJ; Instituto Chileno de Medicina Reproductiva, Santiago, Chile.
  • Ulied A; Centre d'Atèncio Primària, EBA Centelles, Barcelona, Spain.
  • Soerdal T; Medicus, Clinical Trials, Trondheim, Norway.
  • Lazarus E; Perinatal HIV Research Unit, Baragwanath Hospital, Johannesburg, South Africa.
  • Chokephaibulkit K; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Block SL; Kentucky Pediatric and Adult Research, Bardstown.
  • Skrivanek A; G-CENTRUM Olomouc, Olomouc, Czech Republic.
  • Nur Azurah AG; Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
  • Fong SM; Sabah Woman's and Children's Hospital, Hospital Likas, Sabah, Malaysia.
  • Dvorak V; Centrum Ambulantní, Brno, Czech Republic.
  • Kim KH; Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, Republic of Korea.
  • Cestero RM; Women's Research Center of Redlands, Terracina Medical Center, Redlands, California.
  • Berkovitch M; Assaf-Harofeh Medical Center, Zerifin, Israel.
  • Ceyhan M; Hacettepe Üniversitesi Beytepe Kampüsü, Ankara, Turkey.
  • Ellison MC; Merck & Co Inc, Kenilworth, New Jersey.
  • Ritter MA; Merck & Co Inc, Kenilworth, New Jersey.
  • Yuan SS; Merck & Co Inc, Kenilworth, New Jersey.
  • DiNubile MJ; Merck & Co Inc, Kenilworth, New Jersey.
  • Saah AJ; Merck & Co Inc, Kenilworth, New Jersey.
  • Luxembourg A; Merck & Co Inc, Kenilworth, New Jersey.
JAMA ; 316(22): 2411-2421, 2016 12 13.
Article en En | MEDLINE | ID: mdl-27893068

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquemas de Inmunización / Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquemas de Inmunización / Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article